跳至主要内容
临床试验/NCT01876004
NCT01876004已完成4 期

Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy

Federal University of São Paulo1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2011年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
25
试验地点
1
主要终点
success of treatment

研究概览

简要总结

Objectives: To evaluate if, when considering expectant management in tubal ectopic pregnancy if the complementary use of Methotrexate could provide better results. We evaluate the success of treatment and the time required for titers of β-hCG to become negative. Methods: A double-blind randomized study, held at the Department of Obstetrics UNIFESP. The patients will be divided into two groups: in one patients will be administered a single intramuscular dose of 50 mg/m2 of Methotrexate and in the other patients will be prescribed Placebo intramuscularly. The monitoring will be done by measurement of β-hCG in the 4th and 7th day. When the decline of beta-hCG titers was > 15% in this interval, the patient was followed with weekly dosing of β-hCG until the titers become negative. The criterion of success is when the β-hCG was negative. The treatment failure occurs when surgery was necessary.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Hemodynamic stability
  • Initial β-hCG <2000 mIU / mL
  • Titers of β-hCG in decline in 48 hours before treatment
  • Adnexal mass <5.0 cm
  • Desire for future pregnancy

排除标准

  • Alive embryo
  • Ectopic pregnancy other than in tubal location
  • Pregnancy of unknown location

研究组 & 干预措施

Methotrexate

Experimental

Administered a single intramuscular dose of 50 mg/m2 of Methotrexate.

干预措施: Methotrexate (Drug)

Placebo

Placebo Comparator

Prescribed Placebo intramuscularly.

干预措施: Placebo (Drug)

结局指标

主要结局

success of treatment

时间窗: 6 months

β-hCG negative (\<5 mIU / mL)

Time required for titers of β-hCG to become negative

时间窗: 6 weeks

After medication, monitoring will be done by measurement of β-hCG in the 4th and 7th day. If there ia a decrease \> 15% in this range (4th and 7th), patient will be followed with weekly dosing of β-hCG until negative titers

次要结局

  • Blood tests before treatment with Methotrexate and Placebo(6 months)
  • Blood tests after treatment with Methotrexate and Placebo(6 months)

研究者

发起方
Federal University of São Paulo
申办方类型
Other
责任方
Principal Investigator
主要研究者

Priscila Matthiesen e Silva

Obstetrics and Gynecologist

Federal University of São Paulo

研究点 (1)

Loading locations...

相似试验